Document:

Award Agreement

 Exhibit 10.2 
  
 AWARD AGREEMENT 
 UNDER THE WET SEAL, INC. 
 2005 STOCK INCENTIVE PLAN 
  
 THIS AWARD AGREEMENT (this “Agreement”), dated as of July 7, 2005 and effective as of January 1, 2005 (the
“Grant Date”), by and between The Wet Seal, Inc. (the “Company”) and Michael Gold (the “Participant”) who is a consultant to the Company, evidences the grant by the Company of a stock award of
performance shares (the “Performance Shares”) to the Participant and restricted stock (the “Restricted Stock”) under The Wet Seal, Inc. 2005 Stock Incentive Plan, (as amended from time to time the
“Plan”) and the Participant’s acceptance thereof. The Company and the Participant agree as follows: 
  
 1. Basis for Award. The award of the Performance Shares is made under the Plan pursuant to Section 10.1 and the award of the Restricted
Stock is made under Section 9 of the Plan for all services rendered and to be rendered to the Company. There is no Section 162(m) compliance necessary relating to this Award. 
  
 2. Stock Awarded. 
  
 The Company hereby awards to the Participant, an award of Performance Shares and Restricted Stock in an aggregate amount of
5,500,000 shares of Class A common stock (collectively, the “Shares”) which shall be subject to the conditions and restrictions set forth in the Plan and this Agreement. For purposes of this Agreement, 3,500,000 Performance Shares
shall be referred to as “Tranche 1” and “Tranche 2”, and 2,000,000 Restricted Shares shall be referred to as “Tranche 3”, respectively (collectively the “Tranches”). 

 The Shares shall be evidenced by book-entry registration with the Company’s transfer agent, subject
to such stop-transfer orders and other terms deemed appropriate by the Committee to reflect the restrictions applicable to the Shares. Notwithstanding the foregoing, if any certificate is issued in respect of the Shares at the sole discretion of the
Committee, such certificate shall be registered in the name of the Participant and shall bear an appropriate legend referring to the terms, conditions and restrictions applicable to such award, substantially in the following form: 
  
 “THE TRANSFERABILITY OF THIS CERTIFICATE AND THE CLASS A COMMON
STOCK REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS (INCLUDING FORFEITURE) CONTAINED IN THE AWARD AGREEMENT DATED AS OF JANUARY 1, 2005, ENTERED INTO BETWEEN THE REGISTERED OWNER AND THE WET SEAL, INC.” 
  
 If a certificate is issued with respect to the Shares, the Committee may require that the
certificate evidencing such shares be held in custody by the Company until the restrictions thereon shall have lapsed and that the Participant shall have delivered a stock power, endorsed in blank, relating to the shares covered by such Award. At
the expiration of the restrictions, the Company shall instruct the transfer agent to release the shares from the restrictions applicable to such Shares, subject to the terms of the Plan and applicable law or, in the event that a certificate has been
issued, redeliver to the Participant (or his or her legal representative, beneficiary or heir) share certificates for the shares deposited with it without any legend, except as otherwise provided by the Plan, this Agreement or applicable law. During
the period that the Participant holds the Shares, the Participant shall have the right to receive dividends on and to vote the 

  

 2 

 
Shares while it is subject to restriction, except as otherwise provided by the Plan. If the Shares are forfeited, in whole or in part, the Participant will
assign, transfer and deliver any evidence of the Shares to the Company and cooperate with the Company to reflect such forfeiture. By accepting these Shares, the Participant acknowledges that the Company does not have an adequate remedy in damages
for the breach by the Participant of the conditions and covenants set forth in this Agreement and agrees that the Company is entitled to and may obtain an order or a decree of specific performance against the Participant issued by any court having
jurisdiction. 
  
 Except as provided in the Plan or this
Agreement, the restrictions on the Shares are that prior to vesting as provided in Section 3 of this Agreement, the Shares will be forfeited by the Participant and all of the Participant’s rights to such stock shall immediately terminate
without any payment or consideration by the Company, in the event of any sale, assignment, transfer, hypothecation, pledge or other alienation of such Shares made or attempted, whether voluntary or involuntary, and if involuntary whether by process
of law in any civil or criminal suit, action or proceeding, whether in the nature of an insolvency or bankruptcy proceeding or otherwise. Notwithstanding the foregoing, Participant may transfer the Shares to his Immediate Family Members (or to
trusts or partnerships or limited liability companies established for such family members); provided, that, such transfer is for no consideration and effected through such procedures as the Committee may establish from time to time.

  
 3. Vesting. 
  
 The restrictions described in Section 2 of this Agreement will lapse with
respect to 350,000 of the Performance Shares in Tranche 1 if, at any time following the first anniversary of the Grant Date and before the third anniversary of the Grant Date (the “Tranche 1 Vesting 

  

 3 

 
Period”), the weighted average closing price of the Company’s Class A Common Stock (the “Stock”) for any trailing 20
trading days (the “20-Day Average”) during the Tranche 1 Vesting Period equals or exceeds $3.50 per share and the restrictions described in Section 2 of this Agreement will lapse with respect to an additional 350,000 of the
Performance Shares in Tranche 1 (until the entire Tranche 1 is 100% vested) each time the 20-Day Average per share price of the Stock during the Tranche 1 Vesting Period equals or exceeds $4.00; $4.50; $5.00 and $5.50. For the avoidance of doubt, if
the 20-Day Average equals or exceeds $5.50 per share at any time during the Tranche 1 Vesting Period, the restrictions on 100% of Tranche 1 shall lapse. 
  
 The restrictions described in Section 2 of this Agreement will lapse with respect to 350,000 of the Performance Shares in Tranche 2 if, at any time
following the second anniversary of the Grant Date and before the third anniversary of the Grant Date (the “Tranche 2 Vesting Period”), the 20-Day Average during the Tranche 2 Vesting Period equals or exceeds $6.00 per share and the
restrictions described in Section 2 of this Agreement will lapse with respect to an additional 350,000 of the Performance Shares in Tranche 2 (until the entire Tranche 2 is 100% vested) each time the 20-Day Average per share price of the Stock
during the Tranche 2 Vesting Period equals or exceeds $6.50; $7.00; $7.50 and $8.00. For the avoidance of doubt, if the 20-Day Average equals or exceeds $8.00 per share at any time during the Tranche 2 Vesting Period, the restrictions on 100% of
Tranche 2 shall lapse, and further, provided, that the restrictions described in Section 2 of this Agreement will in any event lapse with respect to all the Performance Shares in Tranche 2 which are priced at $6.00 and over at such time
before the third anniversary of the Grant Date as the reported sales per square foot of all Wet Seal Stores open for at least 12 months equal or exceed $350 per square feet for that trailing twelve month period and the weighted average merchandise
margin (internal gross margin) on those sales is at least 59%. 
  

 4 

 The restrictions described in Section 2 of this Agreement shall lapse on January 28, 2006 with respect to
100% of the Restricted Shares in Tranche 3, whether or not you are still employed by the Company. 
  
 If any of the Performance Shares are still outstanding as of the third anniversary of the Grant Date and have not otherwise vested after giving effect to
the vesting provisions of clauses (a) and (b) above, the unvested shares of Stock shall automatically be forfeited without the payment of any consideration to the Participant. 
  
 Except as provided herein, if the Participant ceases to be a Consultant to the Company at any time and for any reason prior
to the vesting of the Performance Shares, all shares that are still outstanding upon such termination of employment shall automatically be forfeited without the payment of any consideration to the Participant upon such cessation of service.
Notwithstanding the foregoing, if Participant’s service is terminated by death or disability, at any time during the Tranche 1 or Tranche 2 Vesting Period, Participant shall continue to vest into the Performance Shares that he would have vested
into, as though he were still employed, for the one-year period following his termination of continuous service (but not beyond the Tranche 2 Vesting Period) but the Restricted Shares shall vest on the date the restrictions thereon would otherwise
lapse, whatever the reason for termination. If Participant’s service is terminated without cause all Restricted and Performance Shares shall immediately vest. The Company acknowledges the Performance Shares will not be forfeited after January
31, 2007, if Participant has performed his services hereunder up until that date. 
  

 5 

 On a change of control, as defined in §2.3 of the Company’s 2005 Stock Incentive Plan, as
amended from time to time, the Restricted and Performance Shares will be immediately vested. 
  
 4. Company; Participant. 
  
 The term “Company” as used in this Agreement with reference to service shall include the Company and its Affiliates, as appropriate. 
  

Whenever the word “Participant” is used in any provision of this Agreement under circumstances where the provision should logically be
construed to apply to the beneficiaries, the executors, the administrators, or the person or persons to whom the Performance Shares may be transferred by will or by the laws of descent and distribution, and as provided in the last sentence of
Section 2(c) hereof the word “Participant” shall be deemed to include such person or persons. 
  
 5. Adjustments. The Award may be adjusted as provided for in Section 12 of the Plan and the Committee shall not exercise any discretion
under Section 10.4 of the Plan to reduce Participant’s award hereunder. 
  
 6. Compliance with Law. Notwithstanding any of the provisions hereof, the Company will not be obligated to issue or transfer any Stock to the Participant hereunder, if the exercise thereof or the
issuance or transfer of such Stock shall constitute a violation by the Participant or the Company of any provisions of any law or regulation of any governmental authority. Any determination in this connection by the Committee shall be final, binding
and conclusive. The Company will take all appropriate steps, including, to the extent necessary, the 
  

 6 

 
filing of an appropriate registration statement at its sole expense, such that Participant may sell Shares upon the lapse of the restrictions set forth
herein (with respect to each group of 350,000 vested Shares), subject to the Company’s insider trading policies. 
  
 7. No Right to Continued Service. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue in the
service of the Company or shall interfere with or restrict in any way the rights of the Company, which are hereby expressly reserved, to terminate the services of or discharge the Participant at any time for any reason whatsoever, with or without
cause. Except as provided herein, Participant acknowledges and agrees that the continued vesting of the Performance Shares granted hereunder is premised upon his provision of future services with the Company and such Performance Shares shall not
accelerate upon his termination of continuous service for any reason. 
  
 8. Representations and Warranties of Participant. The Participant represents and warrants to the Company that: 
  
 Agrees to Terms of the Plan. The Participant has received a copy of the Plan and has read and understands the terms of the Plan and this Agreement,
and agrees to be bound by their terms and conditions. In the event of a conflict or inconsistency between the terms and provisions of the Plan and the provisions of this Agreement, this Agreement shall govern and control. All capitalized terms not
defined herein shall have the meaning ascribed to them as set forth in the Plan. The Participant acknowledges that there may be adverse tax consequences upon the vesting of Performance Shares or disposition of the shares of Stock once vested, and
that the Participant should consult a tax adviser prior to such time. 
  

 7 

 Cooperation. The Participant agrees to sign such additional documentation as may reasonably be
required from time to time by the Company. 
  
 9.
Taxes. 
  
 The Participant agrees that, subject to
clause 9(b) below, no later than the date as of which the restrictions shall lapse with respect to all or any of the Shares covered by this Agreement, the Participant shall pay to the Company (in cash or to the extent permitted by the Board, Stock
held by the Participant for at least six (6) months whose Fair Market Value on the date the Shares vest is equal to the amount of the Participant’s tax withholding liability) any federal, state or local taxes of any kind required by law to be
withheld, if any, with respect to the Shares for which the restrictions shall lapse. The Company or its affiliates shall, to the extent permitted by law, have the right to deduct from any payment of any kind otherwise due to the Participant any
federal, state or local taxes of any kind required by law to be withheld with respect to the Shares. 
  
 If the Participant properly elects to include in gross income for federal income tax purposes an amount equal to the Fair Market Value of the Shares
granted hereunder pursuant to Section 83(b) of the Code, the Participant shall pay to the Company, or make other arrangements satisfactory to the Board to pay to the Company in the year of such grant, any federal, state or local taxes required to be
withheld with respect to such Stock. If the Participant fails to make such payments, the Company or its affiliates shall, to the extent permitted by law, have the right to deduct from any payment of any kind otherwise due to the Participant any
federal, state or local taxes of any kind required by law to be withheld with respect to such Stock. 
  

 8 

 10. Notice. Every notice or other communication relating to this Agreement shall be in
writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided; provided, that,
unless and until some other address be so designated, all notices or communications by the Participant to the Company shall be mailed or delivered to the Company at its principal executive offices, and all notices or communications by the Company to
the Participant may be given to the Participant personally or may be mailed to him at his address as recorded in the records of the Company. Notwithstanding the foregoing, at such time as the Company institutes a policy for delivery of notice by
e-mail, notice may be given in accordance with such policy. 
  
 11. Governing Law. This Agreement shall be construed and interpreted in accordance with the laws of the State of California without regard to its conflict of law principles. 
  

 9 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above
written. 
  

			
	THE WET SEAL, INC.
		
	By:	 	 /s/ Joel Waller

	Name:	 	Joel Waller
	Title:	 	CEO
	
	PARTICIPANT
	
	 /s/ Michael Gold

	Michael Gold

  

 10Consulting Agreement

 Exhibit 10.35 
  
 CONSULTING AGREEMENT 
  
 THIS CONSULTING AGREEMENT (this “Agreement”) is made at Seattle, Washington as of July 12, 2005, by and between Dendreon Corporation, 3005 First
Avenue, Seattle, Washington 98121 (“Dendreon”) and Martin A. Simonetti (“Consultant”). 
  
 WHEREAS, Consultant and Dendreon entered into an Executive Employment Agreement dated October 8, 2004 (the Employment Agreement”); 
  
 WHEREAS, Consultant’s employment with Dendreon will voluntarily
terminate on July 31, 2005 (which date shall constitute both the Termination Date under the Employment Agreement and the Effective Date under this Agreement); and 
  
 WHEREAS, Dendreon desires to secure the services and the availability of Consultant to provide information, analysis and
other services as described below (the “Services”); 
  
 NOW, THEREFORE, Dendreon and Consultant agree as follows: 
  
 1.
Services. Consultant shall provide the Services when and as reasonably requested by Dendreon during the term of this Agreement. The specific time required and the dates of performance of the Services shall be mutually agreed upon by
Consultant and Dendreon. The Services shall include but will not be limited to assistance with the transition of Consultant’s prior responsibilities, including accounting operations, Corporate communications, information technology and
strategic planning. 
  
 2. Compensation and Payment. Dendreon shall pay
Consultant a fee for Services equal to his current base salary of $23,857.09 per month for a period of three (3) months. In addition, Dendreon agrees to pay for continuation of health benefits in effect on the Effective Date and timely elected by
Consultant under COBRA for a period of three months. Consultant will not be reimbursed for any out-of-pocket expenses unless the type and amount of the expense(s) have been approved by Dendreon in advance. Consultant shall be available to provide a
maximum of one hundred sixty (160) hours of Service per month. 
  
 3. Effect on
Options. The parties agree that Consultant’s rendering of Services while this Agreement is in effect shall delay commencement of the three-month maximum exercise period applicable (upon termination of “continuous service”) to the
options granted to Consultant under the 2000 Equity Incentive Plan and the 2002 Broad Based Equity Incentive Plan (the “Plans”) and shall constitute Consultant’s continuous service under the Plans for such purpose; provided, however,
that options granted to Consultant under the Plans that are unvested as of the date of termination of Consultant’s employment with Dendreon shall cease vesting as of such date and shall not continue vesting during the term of this Agreement or
thereafter.  
  
 4. Term and Termination. 
  

 1 

 4.1 Term. This Agreement shall commence on the Effective Date and shall continue
for a period of three (3) months. 
  
 4.2
Effect of Termination. Upon expiration or any termination of this Agreement, (i) Consultant’s continuous service under the Plans shall be deemed to have terminated with regard to the purpose set forth in Section 3 above; and (ii) neither
Consultant nor Dendreon shall have any further obligations under this Agreement, except that any obligations and liabilities accrued through the date of expiration or termination and the provisions of Sections 6, 8, 10 and 11 shall survive
expiration or termination. 
  
 5. Project Representative. Mitchell H. Gold,
M.D., shall be Dendreon’s project representative and shall have primary responsibility for directing and overseeing the services provided by Consultant. 
  
 6. Independent Contractor. Consultant shall provide the Services under this Agreement as an independent contractor and not as an employee of Dendreon. Consultant
shall be responsible for payment of all taxes due on fees that are paid to him for the Services. Consultant is not and shall not be the agent or representative of Dendreon for any purpose under this Agreement and shall not have the power to bind
Dendreon, unless specifically authorized to be and/or do so in particular circumstances. 
  
 7. No License. This Agreement does not and shall not be construed to grant or operate to grant Consultant any license or other right to any patent, trademark, copyright or other intellectual property of
Dendreon. 
  
 8. Confidentiality. 
  
 8.1 Confidential Information. Consultant acknowledges
that Dendreon may provide Consultant with information that is nonpublic or proprietary to Dendreon, including information relating to employees, job descriptions and compensation, methods, techniques and processes, and technical and scientific data,
unpublished findings, biological material, know-how, specifications, patent applications, algorithms, programs, designs, drawings, and formulae, and engineering, manufacturing, marketing, financial and business plans and data (“Confidential
Information”). Confidential Information does not include information that: (i) is or later becomes available to the public through no breach of this Agreement by the Consultant; (ii) is obtained by Consultant from a third party without a
restriction on use or disclosure; (iii) was in the rightful possession of Consultant, without a restriction on use or disclosure, prior to receipt of the information from Dendreon; or (iv) is required to be disclosed in response to a valid order
from a judicial or administrative authority. Consultant will notify Dendreon promptly of any subpoena or court order requesting Confidential Information. 
  

 2 

 8.2 Use and Disclosure of Information. All Confidential Information shall remain
the property of Dendreon. Consultant agrees that he will not, without Dendreon’s prior written authorization, disclose Confidential Information to any third party and that he shall use Confidential Information only for the purpose of providing
the Services. Consultant shall take all reasonable precautions to prevent unauthorized disclosure of any Confidential Information. Consultant additionally acknowledges that Consultant and/or Dendreon may receive information from third parties
subject to a duty on Dendreon’s part to maintain the confidentiality of such information and to use it only for certain limited purposes (“Third Party Information”). Consultant agrees that he will hold Third Party Information in the
strictest confidence and will not disclose it to anyone or use it for any purpose other than performance of the Services, unless expressly authorized in writing by Dendreon. 
  
 8.3 Return of Information; Survival. Upon expiration of this Agreement, and in any case upon
Dendreon’s request, Consultant shall promptly return to Dendreon all Confidential Information and Third-Party Information (along with any and all copies of each) in written, electronic or other form that is in the possession or control of
Consultant. Consultant’s obligations under this Agreement with respect to Confidential Information and Third-Party Information shall survive the expiration of this Agreement without limit as to time. 
  
 9. No Conflicts. Consultant represents and warrants that he is not a party to any
agreement or business relationship that conflicts with the terms of this Agreement or that adversely affects Consultant’s ability to perform the Services for Dendreon. Further, Consultant agrees that he will not enter into any such agreement or
business relationship during the term of this Agreement. 
  
 10. Assignment of
Developments. For purposes of this Section 10, “Developments” means designs, conceptions, innovations, compositions of matter, genetic and biological materials, methods, algorithms, discoveries, formulae, processes, trade secrets,
know-how, inventions, systems, methods, improvements, ideas, works of authorship or copyrightable works. Consultant hereby assigns and agrees to assign to Dendreon or its designee all of his right, title and interest in and to all Developments
conceived, made or reduced to practice in the course of providing Services under this Agreement. To the extent any Development is copyrightable, it is a work made for hire. Consultant shall promptly and fully disclose, by written notice to Dendreon,
any Developments conceived, made or reduced to practice by Consultant or by Consultant working with others, in the course of Consultant’s provision of Services under this Agreement. During and after the term of this Agreement, Consultant agrees
to cooperate fully in obtaining patent, copyright, or other proprietary protection for such Developments, all in the name of Dendreon and at its expense, and shall execute and deliver all requested applications, assignments and other documents, and
shall take such other measures as Dendreon shall reasonably request in order to perfect and enforce Dendreon’s rights in such Developments. 
  

 3 

 11. Cooperation. Consultant agrees to cooperate with Dendreon, including its attorneys and accountants, in connection
with any potential or actual litigation, or other real or potential disputes, which directly or indirectly involves Dendreon. Consultant agrees to appear as a witness and be available to attend depositions, consultations or meetings regarding
litigation or potential litigation as requested by Dendreon. Dendreon acknowledges that these efforts, if necessary, will impose on Consultant’s time. If Consultant’s services are required after October 31, 2005, Consultant agrees to
provide such services subject to the negotiation of a mutually acceptable fee. Dendreon also agrees to reimburse Consultant for any out-of-pocket expenditures actually and reasonably incurred in connection with the performance of services
contemplated by this subsection. It is expressly understood by the parties that any compensation paid by Dendreon to Consultant under this subsection shall be in exchange for consultant’s time and is not intended or understood to be dependent
upon the character or content of any information that consultant discloses in good faith in any such proceedings, meetings or consultations. 
  
 12. Notices. Any written notice required under this Agreement shall be given by reputable overnight courier, or by first class mail, registered or certified with
return receipt requested, at the respective addresses set forth below, or by personal delivery, and shall be effective on the date of actual receipt or the date on which delivery is refused, as the case may be: 
  

			
	Dendreon:	 	General Counsel
	 	 	Dendreon Corporation
	 	 	3005 First Avenue
	 	 	Seattle, Washington 98121
		
	Consultant:	 	Martin A. Simonetti
	 	 	6926 SE 34th Street
	 	 	Mercer Island, WA 98040

  
 13. Severability. If any
provisions, or any portion of any provision, contained in this Agreement is determined to be invalid under any statute or rule of law, then it shall, to that extent alone, be deemed omitted, and the remainder of this Agreement shall remain in full
force and effect. 
  
 14. Governing Law. This Agreement shall be construed
and interpreted in accordance with and governed by the laws of the State of Washington, without giving effect to conflict of law considerations. 
  
 15. Assignment. This Agreement and the rights and obligations hereunder may not be assigned by either Dendreon or Consultant without the other party’s prior
written consent and shall be binding upon and shall inure to the benefit of the parties and their respective successors, permitted assigns and legal representatives. 
  

 4 

 16. Waiver and Modification. Waiver by either party of any default by the other party shall not be deemed a waiver
of any other default. No provision of this Agreement shall be deemed waived, amended or modified by either party, unless such waiver, amendment or modification is in writing and signed by authorized representatives of both parties. 
  
 17. Third-Party Beneficiaries. This Agreement shall not confer any rights or remedies
upon any third party unless such third party is a successor or permitted assign. 
  
 18. Complete Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof, and supersedes all prior or contemporaneous agreements, understandings, proposals and
communications, oral or written, regarding such subject matter. For the purpose of clarity, both the Employee Confidentiality Agreement dated January 1, 1999, the Employment Agreement, the Indemnity Agreement and the Release Agreement between
Consultant and Dendreon shall continue in full force and neither such agreement shall be integrated or otherwise affected by this section or by any other provision of this Agreement. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date. 
  

					
	Martin A. Simonetti	 	DENDREON CORPORATION
			
	 /s/ Martin Simonetti

	 	By:	 	 /s/ Mitchell H. Gold

	Date: July 12, 2005	 	Name:	 	Mitchell H. Gold
	 	 	Title:	 	President & CEO
	 	 	Date:	 	July 12, 2005

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]